ArticleFrontiers in immunology2022

Mesenchymal Stem/Stromal Cell Therapy Is More Cost-Effective Than Fecal Diversion for Treatment of Perianal Crohn's Disease Fistulas.

Sheeva Johnson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.